$0.650
-0.037 (-5.63%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MBRX por análisis de gráficos similares
Alphio's MBRX stock price prediction model matches the current Moleculin Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.64 (-1.90%). The 1-week path is $0.64 (-1.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Moleculin Biotech Inc?
Moleculin Biotech Inc (MBRX) is a good buy right now due to its recent positive clinical trial results showing complete remission rates of 43% for Annamycin, significantly outperforming standard chemotherapy's 12%. The stock has seen a 62.48% increase over the last 20 days, indicating strong momentum. However, the main risk is the company's negative cash flow, with a net income loss of $14.61 million in Q1 2026, which raises concerns about its financial sustainability without further funding.
MBRX cerró en $0.65 el Friday, tras bajar -5.63%
Moleculin Biotech Inc (MBRX) last closed at $0.6499, losing -5.63%. These facts feed the 1-day and 1-week MBRX price prediction above.
Consenso de analistas
Moleculin Biotech Inc (MBRX): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Moleculin Biotech Inc (MBRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MBRX, ordenadas por similitud.
Análisis de estacionalidad de MBRX
Historically the probability of a positive August return for MBRX is 0.00%. January offers the highest probability of a positive month at 45.90%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MBRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.67 | $0.80 | $0.88 | +23.84% |
| Sep 2026 | $0.65 | $0.79 | $0.84 | +21.67% |
| Oct 2026 | $0.76 | $0.84 | $1.01 | +29.43% |
| Nov 2026 | $0.67 | $0.72 | $0.78 | +10.14% |
| Dec 2026 | $0.91 | $0.92 | $0.93 | +41.38% |
En 2026, se proyecta que Moleculin Biotech Inc (MBRX) oscile entre $0.65 y $1.01.
Previsión mensual de Moleculin Biotech Inc para 2026
En Aug de 2026, se proyecta que Moleculin Biotech Inc promedie $0.80, con un mínimo de $0.67 y un máximo de $0.88.
En Sep de 2026, se proyecta que Moleculin Biotech Inc promedie $0.79, con un mínimo de $0.65 y un máximo de $0.84.
En Oct de 2026, se proyecta que Moleculin Biotech Inc promedie $0.84, con un mínimo de $0.76 y un máximo de $1.01.
En Nov de 2026, se proyecta que Moleculin Biotech Inc promedie $0.72, con un mínimo de $0.67 y un máximo de $0.78.
En Dec de 2026, se proyecta que Moleculin Biotech Inc promedie $0.92, con un mínimo de $0.91 y un máximo de $0.93.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.